Follicular lymphoma: open trials in South Korea

15 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT07101328
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Trial Treatment · Phase 1 · Eli Lilly and Company
Asan Medical Center, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-11-04
NCT07519772
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
The Catholic University of Korea, Yeouido St. Mary's Hospital (Site 0801), Seoul · Seoul National University Hospital (Site 0800), Seoul
Registry updated 2026-10-29
NCT07634471
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Samsung Medical Center (Site 0801), Seoul
Registry updated 2026-10-26
NCT06549595
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Trial Treatment · Phase 3 · AstraZeneca
Busan · Goyang-si · Jeonnam · Seoul
Registry updated 2026-10-21
NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Trial Treatment · Phase 1 · Pfizer
Chungnam National University Hospital, Daejeon · Seoul National University Bundang Hospital, Seongnam · Ewha Womans University Mokdong Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-15
NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Trial Treatment · Phase 2 · AstraZeneca
Seoul
Registry updated 2026-10-14
NCT06806033
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Trial Treatment · Phase 2 · Hoffmann-La Roche
Seoul National University Bundang Hospital, Seongnam-si · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul
Registry updated 2026-10-09
NCT06149286
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Pusan National University Hospital, Busan · Inje University Busan Paik Hospital, Busan · Yeyungnam University Medical Center, Daegu · Gachon University Gil Medical Center, Incheon · jeonbuk National University Hospital, Jeonju · Samsung Medical Center, Seoul · Yonsei University Health System, Seoul · Yeouido St. Marys Hospital, Seoul · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · Seoul St. Marys Hospital, Seoul · St. Vincents Hospital - The Catholic University of Korea, Suwon · Ulsan University Hospital, Ulsan
Registry updated 2026-10-07
NCT06091254
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Pusan National University Hospital, Busan · Dong-A University Hospital, Busan · Kyungpook National University Chilgok Hospital, Daegu · Center for Hematologic Malignancy, Goyang-si · jeonbuk National University Hospital, Jeonju · Seoul St. Mary's Hospital, Seoul · Ajou University Hospital, Suwon · St. Vincents Hospital - The Catholic University of Korea, Suwon
Registry updated 2026-10-06
NCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Samsung Medical Center, GangnamGu · The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu · Severance Hospital Yonsei University Health System, SeodaemunGu · Pusan National University Hospital, Seogu · Seoul National University Hospital, Seoul · Asan Medical Center, SongpaGu
Registry updated 2026-10-05
NCT06785818
Long-term Follow up Local Registry Study of Kymriah in South Korea
Research · Novartis Pharmaceuticals
Bundang Gu · Busan · Gyeonggi-do · Incheon · Jeollanam · Seongnam-si · Seoul · Ulsan
Registry updated 2026-07-30
NCT04836507
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients
Trial Treatment · Phase 1/2 · Curocell Inc.
The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Samsung Medical Center, Seoul
Registry updated 2026-07-01
NCT06911502
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Trial Treatment · Phase 3 · Celgene
Seoul · Seoul · Seoul · Seoul
Registry updated 2026-05-20
NCT07473167
Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
Trial Treatment · Phase 1/2 · TICAROS Co., Ltd.
Seoul National University Hospital, Seoul
Registry updated 2026-03-16
NCT07173790
Watch and Wait or Worry and Wait in Indolent Lymphoma
Research · Seoul National University Hospital
Korea UniversityKorea University Guro Hospital, Seoul · Seoul National University Hospital, Seoul · The Catholic University of Korea, Seoul · Samsung Medical Center, Seoul
Registry updated 2025-11-21

All Follicular lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error